Cost Effectiveness of a Diabetes Program in Australia
Author Information
Author(s): Ian S McRae, James R Butler, Beverly M Sibthorpe, Warwick Ruscoe, Jill Snow, Dhigna Rubiano, Karen L Gardner
Primary Institution: Australian Centre for Economic Research on Health, The Australian National University
Hypothesis
Does an integrated approach to diabetes management improve health outcomes and cost effectiveness?
Conclusion
The diabetes program improved health outcomes for type 2 diabetics with acceptable cost effectiveness.
Supporting Evidence
- The program showed improvement in clinical measures over 5 years.
- Average HbA1c levels increased less than expected during the program.
- The program generated treatment cost savings despite positive overall net costs.
- Incremental cost-effectiveness ratios were $A8,106 per life-year saved and $A9,730 per year of QALE gained.
Takeaway
This study shows that a program helping doctors manage diabetes can make patients healthier and save some money, even if it costs more overall.
Methodology
A cost-effectiveness analysis using a decision-analytic approach and the UKPDS Outcomes Model to project long-term outcomes.
Potential Biases
Potential bias due to gaps in data and the observational nature of the study.
Limitations
The study is observational and lacks a formal control group, which may introduce bias.
Participant Demographics
The sample included type 2 diabetic patients from a rural division, with a majority living in small towns.
Statistical Information
P-Value
0.09
Confidence Interval
95% confidence intervals provided for cost and health outcome estimates.
Statistical Significance
p = 0.09
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website